Literature DB >> 7816858

High doses of oxytocin cause sedation and low doses cause an anxiolytic-like effect in male rats.

K Uvnäs-Moberg1, S Ahlenius, V Hillegaart, P Alster.   

Abstract

The aim of the present investigation was to explore dose relationships for effects of oxytocin on spontaneous motor activity in the rat. Oxytocin in doses from 1-1000 micrograms/kg was given SC to male Sprague-Dawley rats, and spontaneous motor behavior was measured by means of photocell-operated open-field observations. In the rats treated with low doses of oxytocin (1-4 micrograms/kg), there was a decrease in peripheral locomotor activity. With increasing doses (250-1000 micrograms/kg), there were clear signs of sedative effects as indicated by a suppression of locomotor activity and rearing. The time course for the effect of oxytocin on peripheral activity (1 microgram/kg) and rearing (1 mg/kg) was tested. A maximal effect was obtained within 1 h and, thereafter, the behavior gradually returned to normal within 24 h. This spectrum of effects caused by oxytocin was similar to that of midazolam but different from that induced by raclopride.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7816858     DOI: 10.1016/0091-3057(94)90462-6

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  49 in total

1.  The psychobiology of emotion: the role of the oxytocinergic system.

Authors:  Kerstin Uvänas-Moberg; Ingemar Arn; David Magnusson
Journal:  Int J Behav Med       Date:  2005

2.  Intergenerational effects of cocaine on maternal aggressive behavior and brain oxytocin in rat dams.

Authors:  M S McMurray; P W Joyner; C W Middleton; T M Jarrett; D L Elliott; M A Black; V E Hofler; C H Walker; J M Johns
Journal:  Stress       Date:  2008-09       Impact factor: 3.493

3.  Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications.

Authors:  Robert H Ring; Jessica E Malberg; Lisa Potestio; Julia Ping; Steve Boikess; Bin Luo; Lee E Schechter; Stacey Rizzo; Zia Rahman; Sharon Rosenzweig-Lipson
Journal:  Psychopharmacology (Berl)       Date:  2006-01-18       Impact factor: 4.530

4.  Oxytocin Reduces Ethanol Self-Administration in Mice.

Authors:  Courtney E King; William C Griffin; Lauryn N Luderman; Malcolm M Kates; Jacqueline F McGinty; Howard C Becker
Journal:  Alcohol Clin Exp Res       Date:  2017-03-27       Impact factor: 3.455

5.  Low Fasting Oxytocin Levels Are Associated With Psychopathology in Anorexia Nervosa in Partial Recovery.

Authors:  Yuliya Afinogenova; Cindy Schmelkin; Franziska Plessow; Jennifer J Thomas; Reitumetse Pulumo; Nadia Micali; Karen K Miller; Kamryn T Eddy; Elizabeth A Lawson
Journal:  J Clin Psychiatry       Date:  2016-11       Impact factor: 4.384

6.  Oxytocin in the prelimbic medial prefrontal cortex reduces anxiety-like behavior in female and male rats.

Authors:  Sara Sabihi; Nicole E Durosko; Shirley M Dong; Benedetta Leuner
Journal:  Psychoneuroendocrinology       Date:  2014-03-29       Impact factor: 4.905

7.  Oxytocin attenuates atherosclerosis and adipose tissue inflammation in socially isolated ApoE-/- mice.

Authors:  Daniel A Nation; Angela Szeto; Armando J Mendez; Larry G Brooks; Julia Zaias; Edward E Herderick; Julie Gonzales; Crystal M Noller; Neil Schneiderman; Philip M McCabe
Journal:  Psychosom Med       Date:  2010-04-05       Impact factor: 4.312

8.  Intracerebroventricular Oxytocin Self-Administration in Female Rats.

Authors:  M E Donhoffner; S P Goings; K Atabaki; R I Wood
Journal:  J Neuroendocrinol       Date:  2016-10       Impact factor: 3.627

Review 9.  The interpersonal dimension of borderline personality disorder: toward a neuropeptide model.

Authors:  Barbara Stanley; Larry J Siever
Journal:  Am J Psychiatry       Date:  2009-12-01       Impact factor: 18.112

Review 10.  Oxytocin and social cognition in rhesus macaques: implications for understanding and treating human psychopathology.

Authors:  Steve W C Chang; Michael L Platt
Journal:  Brain Res       Date:  2013-11-11       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.